With the safety record of Leronlimab...there is NO reason...if we are shaping the trial that the FDA should have objected to 4 DOSES...knowing the results at 7-14-21-28 days...You would have to be totally deranged... NOT to see the efficacy points and how the EXTRA Molecule would have seen greatly improved results...WE wanted 4...They wanted 2...simply the FACTS.